Concepedia

Y. Bao

YB

Statistics

Publications

4

Citations

60

H-Index

4

Active since

2019

Affiliations

Zhejiang Cancer Hospital(Current)

Chinese Academy of Medical Sciences & Peking Union Medical College

BeiGene (China)

Y. Bao is an author at Zhejiang Cancer Hospital specializing in oncology, medicine, and metastatic disease treatment.

ORCID

Publications per year

2019–2023

4

Publications

4

A Preliminary Study on Graduate Student Instructors' Exploration, Perception, and Use of ChatGPT

Y. Bao, Belle Li · International Journal of Computer-Assisted Language Learning and Teaching · 2023 · 26 citations · Full text

, , +15

First report of efficacy and safety from a phase II trial of tislelizumab, an anti-PD-1 antibody, for the treatment of PD-L1+ locally advanced or metastatic urothelial carcinoma (UC) in Asian patients

D. Ye, Jin Liu, Ai-Xu Zhou et al. · Annals of Oncology · 2019 · 12 citations · Full text

, , +12

The effects of tislelizumab plus chemotherapy as first-line treatment on health-related quality of life of patients with advanced squamous non-small cell lung cancer: Results from a phase 3 randomized clinical trial

Jianwei Wang, Xiaoxia Yu, Gisoo Barnes et al. · Cancer Treatment and Research Communications · 2021 · 12 citations · Full text

, , +14

1263P Tislelizumab + chemotherapy vs chemotherapy alone as first-line treatment for locally advanced/metastatic nonsquamous NSCLC

Shun Lü, Yunfang Yu, Xiaoling Yu et al. · Annals of Oncology · 2020 · 10 citations

, , +11

1–4 of 4